This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "OPERA-01 Study - Palazestrant (OP-1250) vs. SoC for ER+/HER2- Advanced/Metastatic BC After ET & CDK4/6i"

38 views
June 11, 2024
Comments 0
Login to view comments. Click here to Login